2004-09-03
Reactogenicity of acellular pertussis vaccine in 4-year-olds in The Netherlands
Publication
Publication
Vaccine , Volume 22 - Issue 25-26 p. 3256- 3257
Aim: To observe reactogenicity of a three-component acellular pertussis (aP) vaccine simultaneously given with dT-IPV vaccine at the age of 4 years. Results: Of 813 subjects 36% had no adverse events. At the first day the score for pain was 47-55% (aP versus dT-IPV), for redness 3-4% and for swelling 5-6%. Irritability and loss of appetite had a score of 20%. In 3% of the children fever was present. Most symptoms disappeared within 3 days. Conclusion: Boostervaccination with an aP vaccine simultaneously given with dT-IPV vaccine at the age of 4 years is well tolerated.
| Additional Metadata | |
|---|---|
| , , | |
| doi.org/10.1016/j.vaccine.2004.03.010, hdl.handle.net/1765/68155 | |
| Vaccine | |
| Organisation | Department of Pediatrics |
|
Keijzer-Veen, M., Holty-Van Der Wekken, L., Juttmann, R., de Groot, R., & Rümke, H. (2004). Reactogenicity of acellular pertussis vaccine in 4-year-olds in The Netherlands. Vaccine, 22(25-26), 3256–3257. doi:10.1016/j.vaccine.2004.03.010 |
|